Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries

scientific article published on 01 January 1984

Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.69.1.1
P698PubMed publication ID6689632

P2093author name stringE Weihe
G Mall
W Kübler
F Schwarz
J Manthey
D Opherk
H Zebe
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectarterial hypertensionQ41861
P304page(s)1-7
P577publication date1984-01-01
P1433published inCirculationQ578091
P1476titleReduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries
P478volume69

Reverse relations

cites work (P2860)
Q93649158Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms
Q52275734An assessment of the distortion of arteries due to sectioning in endomyocardial biopsies.
Q34986413An updated concept for left ventricular hypertrophy risk in hypertension
Q39470341Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia
Q73782365Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy
Q41500182Cardiac effects of calcium antagonists in systemic hypertension
Q64246295Characteristics of coronary artery disease in chronic kidney disease
Q50906480Clinical and angiographic findings in black patients with suspected coronary artery disease.
Q41404103Clinical application of coronary flow reserve using an intracoronary Doppler guide wire
Q90405124Clinical care for patients with recurrent myocardial ischemia in Germany-the VOICES trial
Q33729553Clinical correlation between N-terminal pro-B-type natriuretic peptide and angiographic coronary atherosclerosis
Q39309127Comparative study of coronary flow reserve, coronary anatomy and results of radionuclide exercise tests in patients with coronary artery disease
Q73744496Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina
Q71270580Comparison of relation of systolic flow of the right coronary artery to pulmonary artery pressure in patients with and without pulmonary hypertension
Q40380091Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the rat
Q83924432Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease
Q46435792Coronary angiographic findings in African-American and white patients from a single institution
Q58106412Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy
Q88551207Coronary artery-left ventricular shunt: an important cause of chest pain in patients with hypertrophic cardiomyopathy
Q34118190Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia
Q68409435Coronary flow reserve as a physiologic measure of stenosis severity
Q73226887Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study
Q35376387Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study
Q36830689Coronary haemodynamics in left ventricular hypertrophy
Q46079498Diastolic regional wall motion asynchrony in patients with hypertension
Q27001759Differences in coronary blood flow in aortic regurgitation and systemic arterial hypertension have implications for diastolic blood pressure targets: a systematic review and meta-analysis
Q72189531Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension
Q54376748Effects of vasodilators on the coronary circulation in congestive heart failure.
Q54112242Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.
Q61650837Homogeneously Reduced Versus Regionally Impaired Myocardial Blood Flow in Hypertensive Patients: Two Different Patterns of Myocardial Perfusion Associated With Degree of Hypertrophy
Q38369509Hypertension and left ventricular diastolic function
Q67898638Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease
Q48300541Impaired coronary flow reserve in obstructive sleep apnea and its improvement after continuous positive airway pressure therapy: a transthoracic Doppler echocardiographic study.
Q39287517Impaired myocardial perfusion in patients with hypertrophic cardiomyopathy: assessment with digital subtraction coronary arteriography
Q73708507Intravascular ultrasound findings in patients with abnormal coronary flow reserve after stenting
Q68419569Iodine-123 phenylpentadecanoic acid myocardial scintigraphy in patients with left ventricular hypertrophy: alterations in left ventricular distribution and utilization
Q36894457Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation
Q43693241Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance
Q35047681Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy
Q54470079Management of patients with hypertension and angina pectoris.
Q54302622Mechanisms of angina pectoris in syndrome X.
Q36495359Medical Therapy of the Hypertensive Patient with Concomitant Angina Pectoris
Q45175183Microcirculation in the hypertrophic and ischemic heart
Q72546743Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy
Q35093085Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management
Q73010879Microvascular disease--the Cinderella of uraemic heart disease
Q51824398Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease.
Q83870576Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease
Q34658325Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application
Q35375028Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms
Q34333664Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal findings on angiography.
Q72827369Potassium and the heart
Q71550233Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography
Q46621456Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients
Q35166936Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy
Q33586708Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?
Q46634183Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects.
Q52423069Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease
Q77700083Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery
Q73746088Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus
Q39613149Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina
Q74831159Significance of QTc prolongation on ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension
Q71711873Sudden cardiac death
Q69152697Syndrome X
Q43996819Syndrome X revisited
Q60647431Systemic hypertension and coronary artery disease: the link
Q40380084Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease
Q35660829Target organ involvement in hypertension: a realistic promise of prevention and reversal
Q37514842The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation
Q54041396The influence of left ventricular geometry on coronary vasomotion in patients with essential hypertension.
Q33768923The necessity for recognition and treatment of patients with "mild" hypertension
Q33367466The puzzle of normal coronary arteries in the patient with chest pain: what to do?
Q73272376Three-dimensional reconstruction of abnormal intramural coronary arteries in human cardiac allograft biopsies
Q34173260Transesophageal echocardiography (TEE) in the evaluation of the coronary arteries
Q30535399Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy
Q72100332Usefulness of simultaneous ambulatory electrocardiographic and blood pressure monitoring in detecting myocardial ischemia in patients >70 years of age with systemic hypertension
Q43738902Validation in the canine model of a new non-invasive method of measuring coronary blood flow reserve: split dose thallium-201 rest/stress imaging
Q95466251[Arterial hypertension in patients with coronary artery disease]

Search more.